Skip to Main content Skip to Navigation
Journal articles

Novel inhibitors of human histone deacetylases: Design, synthesis and bioactivity of 3-alkenoylcoumarines

Abstract : Histone deacetylases (HDACs) are well-established, promising targets for anticancer therapy due to their critical role in cancer development. Accordingly, an increasing number of HDAC inhibitors displaying cytotoxic effects against cancer cells have been reported. Among them, a large panel of chemical structures was described including coumarin-containing molecules. In this study, we described synthesis and biological activity of new coumarin-based derivatives as HDAC inhibitors. Among eight derivatives, three compounds showed HDAC inhibitory activities and antitumor activities against leukemia cell lines without affecting the viability of peripheral blood mononuclear cells from healthy donors.
Document type :
Journal articles
Complete list of metadatas

https://hal.univ-lorraine.fr/hal-01494600
Contributor : Srsmc Ul <>
Submitted on : Thursday, March 23, 2017 - 4:42:39 PM
Last modification on : Wednesday, October 28, 2020 - 3:20:08 PM

Identifiers

Collections

Citation

Carole Seidel, Michael Schnekenburger, Clemens Zwergel, François Gaascht, Antonello Mai, et al.. Novel inhibitors of human histone deacetylases: Design, synthesis and bioactivity of 3-alkenoylcoumarines. Bioorganic and Medicinal Chemistry Letters, Elsevier, 2014, 24 (16), pp.3797 - 3801. ⟨10.1016/j.bmcl.2014.06.067⟩. ⟨hal-01494600⟩

Share

Metrics

Record views

148